Clinical trial
Randomized, Controlled Trial Comparing Efficacy of Percutaneous and Intradermal Vaccination With Japanese (Tokyo) 172 BCG in the Prevention of Tuberculosis In Infants Vaccinated at Birth
NCT00242047 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled Trial Comparing Efficacy of Percutaneous and Intradermal Vaccination With Japanese (Tokyo) 172 BCG in the Prevention of Tuberculosis In Infants Vaccinated at Birth
- Lead sponsor
- University of Cape Town
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2001
- Completion date
- August 31, 2006
- Enrollment
- 12,000
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.